Portal field news

Portal field news

in

📊 | Vaccine made from rice that does not require refrigeration Confirmed efficacy and safety for humans The University of Tokyo et al.


写真 

Vaccine made from rice that does not require refrigeration Confirmed efficacy and safety for humans The University of Tokyo et al.

 
If you write the contents roughly
Cholera vaccines currently in use around the world require refrigerated storage.
 

A research team of the University of Tokyo and others has developed a drinking vaccine "Mukorice" to prevent cholera infection. → Continue reading

 Finance newspaper


Wikipedia related words

If there is no explanation, there is no corresponding item on Wikipedia.

Cholera vaccine


Cholera vaccine ThecholeraEffective in preventing infectionvaccineIs[1]..The first 6 months are about 85% effective, and the first year is 50% -60% effective.[1][2][3].. Efficacy after 2 years is less than 50%[1]..Most people are not vaccinated by vaccinationCollective immunityPrevented by[1].

World Health OrganizationRecommends the use of vaccines in combination with other preventative measures for people at high risk of infection. 2-3 oral vaccines are generally recommended[1]..Injectable vaccines are available but not available everywhere in the world[1][2].. Cholera vaccine available for injection in several countries in 2010[1][4].

Oral vaccines are generally safe[1]..Side effects may cause mild abdominal pain and diarrhea[1]. 妊娠InsideLow immune functionCan be safely taken by humans[1]..The use of this vaccine is approved in more than 60 countries[1]..Vaccination in countries with cholera is economically effective[1].

Early cholera vaccines were developed in the late 1800s[5]..The cholera vaccine is the first vaccine made in the laboratory and widely used.[5]..Oral cholera vaccine was used in the 1990s.[1]..This vaccineWorld Health Organization Essential Drug ListIt is described in and is basicMedical systemIs the most important medication in[6]..Cholera vaccine vaccination prices range from 0.10 to US $ 4.0[7].

Source

  1. ^ a b c d e f g h i j k l m “Cholera vaccines: WHO position paper.”. Weekly epidemiological record 13 (85): 117–128. (Mar 26, 2010). PMID 20349546. http://www.who.int/wer/2010/wer8513.pdf. 
  2. ^ a b “Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)”. Cochrane Database Syst Rev (8): CD000974. (2010). two:10.1002 / 14651858.CD000974.pub2. PMID 20687062. 
  3. ^ “Oral vaccines for preventing cholera”. Cochrane Database Syst Rev (3): CD008603. (2011). two:10.1002 / 14651858.CD008603.pub2. PMID 21412922. 
  4. ^ “Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)”. Cochrane Database Syst Rev (8): CD000974. (2010). two:10.1002 / 14651858.CD000974.pub2. PMID 20687062. 
  5. ^ a b Stanberry, Lawrence R. (2009). Vaccines for biodefense and emerging and neglected diseases (1 ed.). Amsterdam: Academic. P. 870. ISBN 9780080919027. https://books.google.ca/books?id=6Nu058ZNa1MC&pg=PA870 
  6. ^ "WHO Model List of Essential Medicines". World Health Organization (June 2013). 2014/4/22Browse.
  7. ^ Martin, S; Lopez, AL; Bellos, A; Deen, J; Ali, M; Alberti, K; Anh, DD; Costa, A et al. (1 December 2014). “Post-licensure deployment of oral cholera vaccines: a systematic review. ”. Bulletin of the World Health Organization 92 (12): 881–93. two:10.2471 / blt.14.139949. PMID 25552772. 

Refrigerated storage


 

Back to Top
Close